Advanced Filters
noise

Neurologic Disorders Clinical Trials

A listing of Neurologic Disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 268 clinical trials
M Matt Butler, MRCPsych MRes

Psilocybin in Functional Neurological Disorder

The goal of this study is to learn about the brain network response in people who have functional neurological disorder who are administered with a single dose of the psychedelic psilocybin with therapeutic support. The main question it aims to answer is: Can the default mode network, a brain network …

25 - 60 years of age All Phase N/A

Integrated Treatment in FND (Functional Neurological Disorders)

The project will investigate the effectiveness of patient-centered integrated treatment. The correlations between physiotherapy indices, non-invasive brain stimulation, connectivity and psychological support will be analyzed.

18 - 65 years of age All Phase N/A

Pilot Neurobehavioral Therapy for Functional Neurological Disorder

The goal of this pilot randomized clinical trial is to learn if Neurobehavioral Therapy (NBT) works to treat motor functional neurological disorder (mFND) (also referred to as functional motor disorder). The main questions it aims to answer are: Does NBT lower mFND symptoms? Does NBT lower common co-occurring symptoms and …

18 - 70 years of age All Phase N/A
D Dang Khoa Nguyen, Md, PhD, Pr

Clinical Evaluation of HRV Biofeedback in Functional Neurological Disorders Compared to Placebo

Evaluation of the clinical effects of the Heart Rate Variability biofeedback training with patients suffering from Functional neurological Disorders compared with placebo.

18 - 70 years of age All Phase N/A

Video Call Assisted Assessment of Acute Stroke

This study aims to investigate whether a live stream video between the on-call neurologist and the emergency medical technicians can increase feasibility and performance of symptom-based prehospital stroke scales.

18 years of age All Phase N/A
Q Qiao mengting

Comprehensive Management of High-risk PopuLatIon of Stroke Based on Social Network

The purpose of this study is to evaluate the effectiveness of social network in improving drug compliance and risk factors control rate of stroke high-risk population after discharge.

18 years of age All Phase N/A

A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

The reason for this study is to assess the safety and efficacy of donanemab in participants with early Alzheimer's disease. The study duration including screening and follow-up is up to 93 weeks.

60 - 85 years of age All Phase 3
C Connie Teo

The SINgapore GERiatric Intervention Study to Reduce Cognitive Decline and Physical Frailty (SINGER) Study

A study in Finland found that a multidomain intervention of physical activity, nutritional guidance, cognitive training, social activities and management of vascular risk factors slowed cognitive decline in healthy older adults at increased risk of cognitive decline. A 6-month pilot study was initiated in Singapore, which demonstrated the cultural feasibility …

60 - 77 years of age All Phase N/A
X Xuhao Zhao, MPH

A Multi-domain Lifestyle Intervention Among Aged Community-residents in Zhejiang, China

A study conducted in Finland discovered that a multidomain intervention, consisting of physical activity, nutritional guidance, cognitive training, social activities, and management of vascular risk factors, effectively decelerated cognitive decline in healthy older adults who were at an increased risk of cognitive decline. The HERITAGE study is a 2-year clustered …

60 - 80 years of age All Phase N/A
K Karen Mulholland Angelus

Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions.

18 years of age All Phase 1/2

Simplify language using AI